Trevena Inc


3 Biotech Stocks Under $2 With Massive Upside Potential

Just in time for Easter, the market delivered two consecutive sessions of gains. All three of the major U.

We Would Be Buyers of Trevena Inc (TRVN) on Share Weakness, Says Aegis

Though Trevena Inc (NASDAQ:TRVN) released positive Phase III trial data read-outs yesterday, shares are dropping 8% today. From the viewpoint of Aegis analyst …

Trevena Inc (TRVN): Olinvo Remains Commercially Viable

Trevena Inc (NASDAQ:TRVN) shares collapsed today, falling nearly 40%, after the pharmaceutical company reported that both Phase 3 oliceridine (Olinvo) trials in post-surgical pain met …

Cowen Raises Price Target for Trevena Inc on Back of Positive Phase 2b Study Data in Postoperative Soft Tissue Pain

In a research report issued today, Cowen analyst Ritu Baral reiterated an Outperform rating on shares of Trevena Inc (NASDAQ:TRVN) and slightly raised the price …

Trevena, Inc. Stock Soars as Analysts Cheer Phase 2b Results for TRV130

Biotechnology company Trevena, Inc. (NASDAQ:TRVN) discovers and develops therapeutics to target G protein coupled receptors, or GPCRs.

Weekend Ideas and Market Takes Report: Biotechnology Sector

Quick SPDR S&P 500 ETF Trust (NYSE ARCA:SPY) forecast update:  Back on November 10th 2014 we predicted a spring 2015 high of 2181 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts